2020-2027 Analysis and Review High Definition Breast Tomosynthesis Market

High Definition Breast Tomosynthesis Market

High Definition Breast Tomosynthesis Market By Product (2D/3D Combination Systems and Standalone 3D Systems), By End User (Hospitals, Diagnostic Centers and Others)- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

01-02-2020 REP-HC-5027 40 Tables 120 pages Format

The high definition of the breast tomosynthesis market was valued at USD1,588.0 Mn by 2019. As per the latest statistics provided by the American Institute for Cancer Research in 2018 approximately 2 million new cases of breast cancer in women were reported. Increasing public health awareness regarding breast cancer and its early screening is primarily determining the high definition of breast tomosynthesis market.

 High Definition Breast Tomosynthesis Market

Breast tissue varies at different stages of life in response to hormones and other environmental factors. Breast cancer cells that possess the estrogen receptors are called as ER+ and those possessing progesterone receptors are called as PR+ cancer cells. Some inherent mutations associated with breast cancer are BRCA1, BRCA2, and p53, etc., it is noteworthy to mention that germline mutations in these genes are infrequent and therefore account for only 2 to 5% breast cancer cases. High definition breast tomosynthesis produces high-resolution images and is superior in its prognosis in comparison to digital mammography. It usually employs an x-ray tube which basically moves like an arc taking low radiation dose, obtaining images of the breast from various angles for multiple data points which can be reconstructed in different ways to perform an accurate diagnosis of breast cancer.

The major segments related to the high definition breast tomosynthesis market are:

By Product (2017–2027; US$ Mn)

2D/3D Combination Systems

Standalone 3D Systems

By End User (2017–2027; US$ Mn)

Hospital

Diagnostic Centers

Others

Geography Segment(2017–2027; US$ Mn)

North America

United States
Canada

Europe

United Kingdom
Germany
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global high definition breast tomosynthesis market
  • The overall segmentation of the high definition breast tomosynthesis market, by product, end-user, and geography is minutely studied. 2D/3D combination systems and hospitals are dominating the product and end-user segments respectively
  • Rising prevalence of breast cancer worldwide and technological advancement in the radiology diagnostic techniques further accelerate the high definition breast tomosynthesis market
  • Rising public health awareness further increases the demand for diagnosis of breast cancer has a positive impact on the market growth of high definition breast tomosynthesis market

Report gist?

  • The study of the global high definition breast tomosynthesis market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers qualitative and quantitative analysis of the overall market segmented on the basis of product and end-user and categorization of the same at geography level
  • This research report presents the analysis of each segment from 2017 to 2027 considering 2019 as the base year for the research. CAGR for each respective segments are calculated for the forecast period from 2020 to 2027
  • The study includes the profiles of major market players with a significant global and regional presence along with top company positioning

Significant customers?

  • This study is suitable for industry participants and stakeholders in the medical device manufacturers engaged in manufacturing and marketing of high definition breast tomosynthesis which is gaining huge demand owing to the rising prevalence of breast cancer
  • The report will benefit radiologist engaged in the diagnosis of breast cancer
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to high definition breast tomosynthesis market
  • Financial institutions venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies

Segment Analysis

In the current situation the 2D/3D combination systems are holding the largest market share in the high definition breast tomosynthesis market. The chief parameter which increases its popularity among radiologist for effective diagnosis of breast cancer is the ability of this combination system to precisely analyze the calcification and non-calcification cases of breast images which are very difficult to interpret with either dimensional system. 3D standalone systems are gaining huge popularity on account of its excellent ergonomic features such as improved sensitivity and reduced recalls which have made it capable to diligently detect invasive cancer cases and false-positive cases have decreased.

Hospitals are dominating the end-user segment for high definition breast tomosynthesis market. It is the first point of contact for patients opting for early screening of breast cancer. Healthcare agencies worldwide are providing huge funds to install state of the art breast screening devices in the primary healthcare centers. Diagnostic centers are gaining immense popularity in the developing regions on account of the presence of a skilled workforce to perform an accurate diagnosis of breast cancer and diligently handle the sophisticated high definition breast tomosynthesis device.

In the present scenario North America is spearheading the geography segment for high definition breast tomosynthesis market. The rising prevalence of breast cancer in the adult population determines the market growth in the region. As per the latest statistics provided by the American Cancer Society (ACS), in 2019 in the United States approximately 268,600 new cases of breast cancer were diagnosed in women and 2,670 were diagnosed in men. Domicile of major manufacturers of high definition breast tomosynthesis such as Siemens Healthineers, GE Healthcare, Hologic, Inc. further accelerate the market growth in the region. As per the latest research citings brought forward by the European Breast Cancer Coalition in 2018, approximately 562,500 women were suffering from breast cancer in Europe. The strategic collaboration between academic research institutes and medical device manufacturers to upgrade the technology of high definition breast tomosynthesis will propel the market growth in Europe. It is anticipated that the Asia Pacific is keen to register sturdy market growth during the forecast period on account of rising public health awareness pertaining to breast cancer and its early screening and developing healthcare infrastructure.

Select License Type

$4,600
$6,600
$9,500

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.